Related Experiment Videos
Lipid and biochemical changes after low-dose oral contraception
1Department of Obstetrics and Gynecology, National University Hospital, National University of Singapore.
Contraception
|September 1, 1992
Summary
This study on combined oral contraceptives found that while norethisterone/ethinyl estradiol (NET/EE) and levonorgestrel/ethinyl estradiol (LNG/EE) pills altered glucose and lipid profiles, most metabolic changes were not clinically significant compared to intrauterine devices (IUDs).
Area of Science:
- Endocrinology
- Pharmacology
- Metabolic Medicine
Background:
- Combined oral contraceptives (COCs) are widely used for family planning.
- Understanding the metabolic effects of low-dose COCs is crucial for patient safety and informed prescribing.
- Previous studies have shown mixed results regarding the metabolic impact of different COC formulations.
Purpose of the Study:
- To evaluate and compare the metabolic effects of two low-dose combined oral contraceptives (norethisterone/ethinyl estradiol and levonorgestrel/ethinyl estradiol) versus intrauterine devices (IUDs) in Singaporean women.
- To assess changes in glucose metabolism, lipid profiles, and liver function parameters.
Main Methods:
- A randomized, double-blind study involving 58 women allocated to either NET/EE (n=29) or LNG/EE (n=29) COCs, and 23 women using IUDs as controls.
- Blood samples were collected at baseline, 3 months, and 12 months for metabolic parameter analysis.
- Key parameters included fasting and 2-hour glucose, triglycerides, total cholesterol, HDL, LDL, and liver function tests.
Main Results:
- The NET/EE group showed decreased fasting glucose and increased 2-hour glucose and triglycerides. The LNG/EE group had increased 2-hour glucose and decreased LDL cholesterol and total cholesterol at specific time points.
- Both COC groups experienced suppressed alkaline phosphatase, bilirubin, and SGOT. NET/EE also significantly suppressed albumin.
- Metabolic changes, except for 2-hour glucose, were not significantly different between COC groups and the IUD control group, with many liver function parameters showing improvement.
Conclusions:
- Low-dose COCs, NET/EE and LNG/EE, induce some metabolic alterations, particularly in glucose metabolism.
- Most observed metabolic changes, including lipid profiles and liver function, were not clinically significant when compared to IUD use.
- Except for potential glucose intolerance, the metabolic profile changes associated with these COCs are generally considered safe.
Keywords:
AsiaBiologyContraceptionContraceptive AgentsContraceptive Agents, EstrogenContraceptive Agents, FemaleContraceptive Agents, ProgestinContraceptive MethodsDeveloping CountriesDouble-blind StudiesEthinyl EstradiolFamily PlanningIudLevonorgestrelLipidsMetabolic EffectsOral ContraceptivesPhysiologyResearch MethodologyResearch ReportSingaporeSoutheastern AsiaStudies